Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia

Autor: Khamis, Faryal, Al Naabi, Hanan, Al Lawati, Adil, Ambusaidi, Zaiyana, Al Sharji, Mariam, Al Barwani, Umkulthum, Pandak, Nenad, Al Balushi, Zakariya, Al Bahrani, Maher, Al Salmi, Issa, Al-Zakwani, Ibrahim
Zdroj: In International Journal of Infectious Diseases January 2021 102:538-543
Databáze: ScienceDirect